Lpl Financial LLC Evogene Ltd. Transaction History

Lpl Financial LLC

$196 Billion
Q2 2024

A detailed history of Lpl Financial LLC transactions in Evogene Ltd. stock. As of the latest transaction made, Lpl Financial LLC holds 67,335 shares of EVGN stock, worth $154,197. This represents 0.0% of its overall portfolio holdings.

Number of Shares

67,335

Previous 66,835 0.75%

Holding current value

$154,197

Previous $50,000 14.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$0.61 - $0.82 $305 - $410	500 Added 0.75%	67,335 $43,000
Q3 2023 Nov 13, 2023	BUY	$0.58 - $1.41 $145 - $352	250 Added 0.38%	66,835 $39,000
Q2 2023 Jul 31, 2023	BUY	$0.56 - $1.2 $280 - $600	500 Added 0.76%	66,585 $71,000
Q1 2023 May 10, 2023	BUY	$0.59 - $0.86 $1,180 - $1,720	2,000 Added 3.12%	66,085 $41,000
Q4 2022 Feb 07, 2023	SELL	$0.61 - $8.13 $4,392 - $58,536	-7,200 Reduced 10.1%	64,085 $44,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $8.65 $912 - $10,812	-1,250 Reduced 1.72%	71,285 $59,000
Q2 2022 Aug 12, 2022	SELL	$0.75 - $1.33 $5,325 - $9,443	-7,100 Reduced 8.92%	72,535 $56,000
Q1 2022 May 16, 2022	SELL	$1.09 - $1.83 $4,441 - $7,457	-4,075 Reduced 4.87%	79,635 $104,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $2.83 $18,989 - $32,969	11,650 Added 16.17%	83,710 $137,000
Q3 2021 Nov 15, 2021	BUY	$2.45 - $3.45 $30,808 - $43,383	12,575 Added 21.14%	72,060 $190,000
Q2 2021 Aug 13, 2021	BUY	$3.3 - $5.02 $35,062 - $53,337	10,625 Added 21.75%	59,485 $203,000
Q1 2021 May 14, 2021	BUY	$4.29 - $9.94 $39,768 - $92,143	9,270 Added 23.42%	48,860 $246,000
Q4 2020 Feb 12, 2021	BUY	$2.41 - $5.63 $95,411 - $222,891	39,590 New	39,590 $186,000

Others Institutions Holding EVGN

# of Institutions

Shares Held

3.9M

Call Options Held

400

Put Options Held

View Full List

About Evogene Ltd.

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $94.4M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

More about EVGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Evogene Ltd. Transaction History